Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Rapid detection of SARS CoV-2 N501Y mutation in clinical samples

Sirwan M.A. Al-Jaf, View ORCID ProfileSherko Subhan Niranji
doi: https://doi.org/10.1101/2021.04.17.21255656
Sirwan M.A. Al-Jaf
1Department of Biology, College of Education, University of Garmian, Kurdistan Region, Iraq
2Coronavirus Research and Identification Lab., University of Garmian, Kurdistan Region, Iraq
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherko Subhan Niranji
1Department of Biology, College of Education, University of Garmian, Kurdistan Region, Iraq
2Coronavirus Research and Identification Lab., University of Garmian, Kurdistan Region, Iraq
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sherko Subhan Niranji
  • For correspondence: sherko.subhan@garmian.edu.krd
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) variants poses major threats in increasing infectivity, transmission, mortality of Coronavirus Disease 2019 (Covid-19). Additionally, SARS CoV-2 variants resist antibody neutralizations or may abolish vaccine efficacies. Researches to develop economical and fast methods will support the developing or poor countries to challenge the Covid-19 pandemic via tracking common mutations that may help to deploy the vaccination programs and control the virus. Current study has developed a novel low-cost rapid technique, exploiting real time PCR probes and conventional PCR specific primers, to identify N501Y mutation, which was independently emerged in the UK, South African and Brazilian variants. Currently, these variants tend to spread to all over the world and seem to be more infectious, transmissible and fatal. This study helps tracking the N501Y mutation for understanding its clinical and epidemiological characteristics, in those countries where sequencing facilities are lacking or expensive. Further study should focus on other common mutations in the variants of concerns of SARS CoV-2.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funds were provided for this research

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Consent forms were filled by the participants and the study was approved by an ethical committee at the Department of Biology, University of Garmian that follow the rules adhered to the Declaration of Helsinki for human and animal research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

). Two mutants and 4 wildtypes PCR products, amplified by conventional PCR amplifying 748 bp in the spike protein at the region of variants of concerns (Figure 3C), were confirmed using Sanger sequencings and the GenBanks (MW897351, MW897352, MW897353, MW897354, MW897355, and MW897356) were released to NCBI data base.

https://www.ncbi.nlm.nih.gov/nuccore/MW897351

https://www.ncbi.nlm.nih.gov/nuccore/MW897352

https://www.ncbi.nlm.nih.gov/nuccore/MW897353

https://www.ncbi.nlm.nih.gov/nuccore/MW897354

https://www.ncbi.nlm.nih.gov/nuccore/MW897355

https://www.ncbi.nlm.nih.gov/nuccore/MW897356

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted April 20, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Rapid detection of SARS CoV-2 N501Y mutation in clinical samples
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rapid detection of SARS CoV-2 N501Y mutation in clinical samples
Sirwan M.A. Al-Jaf, Sherko Subhan Niranji
medRxiv 2021.04.17.21255656; doi: https://doi.org/10.1101/2021.04.17.21255656
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Rapid detection of SARS CoV-2 N501Y mutation in clinical samples
Sirwan M.A. Al-Jaf, Sherko Subhan Niranji
medRxiv 2021.04.17.21255656; doi: https://doi.org/10.1101/2021.04.17.21255656

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (520)
  • Anesthesia (124)
  • Cardiovascular Medicine (1417)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10279)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2621)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1728)
  • Health Policy (788)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12078)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (288)
  • Neurology (2451)
  • Nursing (144)
  • Nutrition (377)
  • Obstetrics and Gynecology (489)
  • Occupational and Environmental Health (566)
  • Oncology (1318)
  • Ophthalmology (400)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (329)
  • Primary Care Research (295)
  • Psychiatry and Clinical Psychology (2393)
  • Public and Global Health (4994)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (523)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (254)
  • Sports Medicine (244)
  • Surgery (297)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)